creation in 2000, CIHR alone has invested more than $100 million dollars in research into infectious diseases, including HIV/AIDS, hepatitis C, Mad Cow Disease, and now SARS. CIHR's Institute of Infection and Immunity, with more than 15 partners in the food production, health and environmental research sectors, has also launched a major research initiative on the safety of Canada's food and water supply.
In a unique trans-Canada partnership, four CIHR-funded research teams dropped what they were doing and in just 11 weeks from recognizing a new coronavirus associated with SARS, completed and announced to the world the complete sequence of this virus on April 13. Now the entire world can build on this outstanding Canadian accomplishment to understand the virus, and develop diagnostic tests, a vaccine and antiviral therapies.
Think of it -it took almost a decade to obtain the complete sequence of HIV, the virus that causes AIDS. Today, thanks to the spectacular advances in health research and DNA sequencing technology, we now know the most intimate secrets of this coronavirus in a matter of weeks.
The sequencing of the SARS genome is just the first step in the scientific journey to understand this virus and defeat it. With our partners, CIHR has developed a three-pronged strategy against SARS.
First, CIHR's Institute of Infection and Immunity, with our partners from industry, research agencies in the provinces of Ontario, British Columbia and Quebec, health charities, federal networks in vaccines, protein engineering and mathematics, and Health Canada, have funded four research teams in Quebec City, Toronto, Hamilton and Vancouver to understand the severe lung disease caused by the virus, develop a rapid diagnostic test, engineer a vaccine and develop antiviral drugs.
Second, four of CIHR's Institutes, with our partners, will select more research teams that will examine and evaluate the public health and healthcare system's response to the SARS outbreak.
Third, we announced the formation of the Canadian SARS Research Consortium (CSRC), a unique public-private partnership that will develop an integrated national, and ultimately international, strategy to coordinate, catalyze and fund research on SARS. The goals of this are to understand the virus and control it. And we should be clear -our war against SARS, and other emerging infectious diseases, will only succeed if we bring every available weapon to bear -not
just face masks and quarantine procedures, but also virology, immunology, proteomics, combinational chemistry, epidemiology, public health and healthcare system research.
Attracting and retaining the very best health researchers, and providing them and their trainees with the very best facilities to do their research, are vitally important. Creating an environment of collegiality, partnership and public service -core Canadian values -has also been key so far in the SARS saga, both among our researchers also, of course, among the front-line healthcare workers who have put themselves and their families in danger during the course of their work.
Canada has much to be proud of in this story, from the dedication of our healthcare and public health workers to the responsiveness and excellence of Canada's health research community.
As a scientist and virologist, I can't wait to find out how the SARS virus causes such devastation. As a member of Canada's health research community, no one will be prouder when Canadian research teams, funded by CIHR and our partners, contribute to successful global efforts to combat this and the literally hundreds of other diseases that still affect human kind.
No one could have predicted the SARS outbreak and no one can predict future outbreaks. What we can predict, and plan for, is the ability of our country to be able to respond quickly and effectively when future outbreaks arise. A sustained investment in health research will allow us to respond.
Alan Bernstein, OC, PhD, FRSC, is President of the Canadian Institutes of Health Research. Dr. Bernstein is known internationally both as a researcher and as a scientific leader. His pioneering research results in the area of cancer, hematopoiesis and gene therapy remain landmarks in their field. For more information see www.cihr.ca.
Are you a physician leader?
Increasingly physicians are seen as instrumental participants in the management of Canada's health care system. The Canadian Society of Physician Executives (CSPE) can offer physicians the opportunity to develop the necessary skills and gain knowledge to excel as leaders in these management positions.
Who should join
All physician managers, physician executives and any other physician interested in enhancing their effectiveness and involvement in system, institutional, organization or group management.
Benefits of joining
• quarterly CSPE Newsletter -a highly valued information source for Canadian physician executives • CSPE annual meeting -your opportunity to meet face-to-face with colleagues and learn from one another • physician management education -developed in collaboration with the Canadian Medical Association's Physician Manager Institute (PMI) to provide you with the latest management skills and information
• online Q&A program -colleagues from around the country can provide answers to your most challenging management questions. 
